Research programme: rhomboid protease inhibitors - Academy of Sciences Czech Republic/Enamine/MRC
Latest Information Update: 16 Jul 2016
At a glance
- Originator Academy of Sciences of the Czech Republic; Enamine; Medical Research Council
- Class Small molecules
- Mechanism of Action Rhomboid protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Cardiovascular disorders; Immunological disorders; Infections; Parasitic infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Czech Republic
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in Ukraine
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in United Kingdom